Discovery of α-Glucosidase Inhibitors from Marine Microorganisms: Optimization of Culture Conditions and Medium Composition

Various studies showed that the suppression of alpha-glucosidase activity can impede the glucose absorption in our body, and therefore, it can be used to treat type 2 diabetes. Hence, the compounds with anti-alpha-glucosidase have gained considerable attention because of their potential application in diabetes treatment. In previous literature studies, these anti-alpha-glucosidase compounds were extracted from plants and fungus. Less studies are being conducted to identify the anti-alpha-glucosidase compounds in the microbial community. In this study, 23 marine bacterial strains were screened for their potential to suppress the alpha-glucosidase activity. The highest inhibitory activity was exhibited by isolated L06 which was identified as Oceanimonas smirnovii EBL6. The cultivation conditions, such as temperature and pH, were optimized to increase the production of alpha-glucosidase inhibitors by Oceanimonas smirnovii EBL6 strain. The result findings showed that the highest yield of alpha-glucosidase inhibitors can be obtained at the culture time of 120 h, fermentation temperature of 30 degrees C, and pH 4.6. Under these conditions, the inhibitory activity of alpha-glucosidase can reach 81%. The IC50 of n-butanol extract was 13.89 mu g/ml, while standard acarbose was 31.16 mu g/ml. Overall, these findings suggest that Oceanimonas smirnovii produces alpha-glucosidase inhibitors and could been applied in the biochemical and medicinal fields in the future.